These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 19632771
1. Down-regulation of RIP expression by 17-dimethylaminoethylamino-17-demethoxygeldanamycin promotes TRAIL-induced apoptosis in breast tumor cells. Palacios C, López-Pérez AI, López-Rivas A. Cancer Lett; 2010 Jan 28; 287(2):207-15. PubMed ID: 19632771 [Abstract] [Full Text] [Related]
2. Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis. Palacios C, Martín-Pérez R, López-Pérez AI, Pandiella A, López-Rivas A. Leuk Res; 2010 Nov 28; 34(11):1533-8. PubMed ID: 20667592 [Abstract] [Full Text] [Related]
3. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions. Meurette O, Rebillard A, Huc L, Le Moigne G, Merino D, Micheau O, Lagadic-Gossmann D, Dimanche-Boitrel MT. Cancer Res; 2007 Jan 01; 67(1):218-26. PubMed ID: 17210702 [Abstract] [Full Text] [Related]
4. [Effect of heat shock protein 90 inhibitor 17-dimethylamino-ethylaminogeldanamycin on TNfalpha-mediated apoptosis and TNF-induced NF-kappaB activation]. Zhong YJ, Wang X, Zheng XL, Yan YY, Liu XM, Liao LC. Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May 01; 42(3):303-7. PubMed ID: 21826987 [Abstract] [Full Text] [Related]
5. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Zhang Z, Li HM, Zhou C, Li Q, Ma L, Zhang Z, Sun Y, Wang L, Zhang X, Zhu B, Hong YS, Wu CZ, Liu H. J Exp Clin Cancer Res; 2016 Sep 22; 35(1):149. PubMed ID: 27658586 [Abstract] [Full Text] [Related]
6. Heat shock protein 90 inhibitor regulates necroptotic cell death via down-regulation of receptor interacting proteins. Park SY, Shim JH, Chae JI, Cho YS. Pharmazie; 2015 Mar 22; 70(3):193-8. PubMed ID: 25980180 [Abstract] [Full Text] [Related]
7. Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin. Ma Y, Lakshmikanthan V, Lewis RW, Kumar MV. Mol Cancer Ther; 2006 Jan 22; 5(1):170-8. PubMed ID: 16432176 [Abstract] [Full Text] [Related]
8. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A. Clin Cancer Res; 2006 Jan 15; 12(2):584-90. PubMed ID: 16428504 [Abstract] [Full Text] [Related]
9. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Sun J, Yu X, Wang C, Yu C, Li Z, Nie W, Xu X, Miao X, Jin X. Med Sci Monit; 2017 Mar 08; 23():1190-1199. PubMed ID: 28270653 [Abstract] [Full Text] [Related]
10. Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells. Mellatyar H, Talaei S, Nejati-Koshki K, Akbarzadeh A. Asian Pac J Cancer Prev; 2016 Mar 08; 17(5):2453-7. PubMed ID: 27268613 [Abstract] [Full Text] [Related]
11. 17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion. Kim MS, Kwak HJ, Lee JW, Kim HJ, Park MJ, Park JB, Choi KH, Yoo H, Shin SH, Shin WS, Song ES, Lee SH. Mol Cancer Res; 2008 Nov 08; 6(11):1657-65. PubMed ID: 18974397 [Abstract] [Full Text] [Related]
12. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C. Cell Signal; 2007 Nov 08; 19(11):2237-46. PubMed ID: 17693058 [Abstract] [Full Text] [Related]
13. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH, Hodnett M, Abayasiriwardana KS, Roux J, Howard M, Broaddus VC, Pittet JF. Cancer Res; 2007 Mar 15; 67(6):2865-71. PubMed ID: 17363610 [Abstract] [Full Text] [Related]
14. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells. Lee DH, Sung KS, Bartlett DL, Kwon YT, Lee YJ. Cell Signal; 2015 Feb 15; 27(2):293-305. PubMed ID: 25446253 [Abstract] [Full Text] [Related]
15. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929. Park SY, Shim JH, Cho YS. Cell Biochem Funct; 2014 Jan 15; 32(1):62-9. PubMed ID: 23584955 [Abstract] [Full Text] [Related]
16. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Ortiz-Ferrón G, Yerbes R, Eramo A, López-Pérez AI, De Maria R, López-Rivas A. Cell Res; 2008 Jun 15; 18(6):664-76. PubMed ID: 18458681 [Abstract] [Full Text] [Related]